Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Castle Creek buys EB partner Fibrocell for $63mm

Executive Summary

Castle Creek Pharmaceuticals LLC (CCP) agreed to acquire its partner, public US biotech Fibrocell Science Inc. (autologous cell-based therapies for skin and connective tissue diseases) for $3 in cash per share (a 60% premium). The deal was already unanimously approved by both boards and is expected to close in Q4 2019.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies